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Executive Summary
This project report summarizes the work of a joint expert group on data collection of the Correlation 
network, the EMCDDA and National Reitox Focal Points (1) to develop a protocol for collecting data 
on harm reduction services provision. This protocol is aimed for the use by specialist agencies which 
provide health and social services to current drug users. The underlying purpose of such a protocol is 
to increase the quality of information on harm reduction, including at national, regional and EU levels, 
by collecting data on availability and access to services in a standardized way.
The core-element of the protocol is an agency inventory, a questionnaire where each agency 
describes its operational framework, characteristics and the services it provides. It includes: adminis-
trative information on staffing, management and funding; data on the range of facilities and services 
offered at the agency; on quality standards and on data-collection routines. It also contains information 
on the target population and on new drug use-related phenomena or problems that have come to the 
attention of the agency’s staff in the course of their work with current drug users. 
The protocol has its technical manual which provides instructions on how to complete the inventory 
and defines the terms that have been used. It furthermore contains a list of core-services, representing 
different areas of activity of harm reduction agencies, which have been selected as proxy indicators for 
ongoing monitoring. A description of different approaches to monitoring the level of access to these 
core-services is also provided.
The present report provides a description of the field test, conducted in Summer/Autumn 007 with 15 
voluntary agencies from Austria, Bulgaria, Catalonia, France, Hungary, Poland and Portugal as well as 
by the main harm reduction agency in Teheran (Iran) and presents an evaluation of the results. The final 
version of the data collection protocol is annexed to this report.
1  The European Monitoring Center for Drugs and Drug Addiction (EMCDDA) coordinates a network of 
National focal points (NFPs) set up in the 7 EU Member States, Norway, the European Commission and in the 
candidate countries to the EU. Together, these information collection and exchange points form Reitox (Réseau 
Européen d’Information sur les Drogues et la Toxicomanie), the European Information Network on Drugs and Drug 
Addiction. National Focal Points are the national authority providing drug information to the EMCDDA and act as an 
interface between Member State and EMCDDA, coordinating and stimulating data collection.
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1. Context and objectives
1.1 Role of harm reduction in Europe
The aims of a harm reduction approach are to prevent and reduce health-related harm associated with 
drug dependence, in particular the incidence of blood-borne viral infections and overdoses, and to en-
courage active drug users to contact health and social services.  A broad agreement on the relevance 
of the approach, as part of a comprehensive strategy to respond to drug use, is reflected in previous 
and current EU drugs strategies (), which include besides prevention, treatment and supply reduction 
also measures to prevent and reduce health-related harm.  
To increase drug users’ access to services that help prevent and reduce health-related harm as-
sociated with drug use has become a public health objective in the European countries. Within the 
comprehensive systems of care for drug users that are common in the EU, low-threshold agencies 
play an important role for increasing drug users’ access to care. These agencies are not only consid-
ered essential for delivering basic health and social care to current drug users, but are recognized as 
important points for entering into contact with populations of drug users that are ‘hidden’, that are 
more difficult to reach or have lost contact with the care system.
1. European data collection on harm reduction 
A Council Recommendation, adopted on 18 June 003(3), recommends a number of facilities and 
services for the prevention and reduction of health-related harm associated with drug dependence that 
the EU Member States should provide. The implementation of the Recommendation was evaluated 
through a consultant study(4) which formed the basis for a report by the European Commission to the 
European Parliament and the Council (5). 
The consultant report documented that all Member States have policies and actions in place that to a 
large extent reflect the recommended measures, but that the level of implementation is variable within 
and between countries. While it was still early to assess the real impact of the Recommendation, it 
was also concluded that the Recommendation had set a ‘benchmark’ for policies. The available data 
showed that the prevention and reduction of health-related harm is a defined public health objective 
in all countries, and that services and facilities are available (although in some countries to a lesser 
extent). 
However, the report also highlighted the need to improve data on accessibility and utilization of serv-
ices and facilities, and to strengthen monitoring, research and evaluation of harm reduction in future 
years. Only few countries have defined national standards for the documentation of service delivery 
at specialist harm reduction agencies or are recording data according to the EMCDDA Treatment De-
mand protocol. Documentation at the agencies is primarily orientated to fulfill obligations of account-
ability towards funding bodies. Where harm reduction funding comes from local budgets, data-flow 
does not go beyond city or regional level. The  lack of standardized reporting is a handicap to obtain-
ing a reliable overview at national (and subsequently European) level. 
The report by the European Commission confirmed the results of expert meetings organized by the 
  The EU Drugs Strategy (005 – 01) is available online at: http://register.consilium.europa.eu/pdf/
en/04/st15/st15074.en04.pdf ; and the EU Drugs Action Plan (005-008) at : http://eur-lex.europa.eu/LexUriServ/
LexUriServ.do?uri=CELEX:5005XG0708(01):EN:NOT
3  Available online at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:003:165:0031:0033:
EN:PDF
4  Trimbos Institute (006). Prevention and reduction of health-related harm associated with drug depend-
ence. An inventory of policies, evidence and practices in the EU relevant to the implementation of the Council 
Recommendation of 18 June 004. Netherlands Institute for Mental Health: Utrecht.
5  Report COM (007) 199 final of 18.4.007 - Commission of the European Communities (COM). (007). 
Report from the Commission to the European Parliament and the Council on the implementation of the Council 
Recommendation of 18 June 003 on the prevention and reduction of health-related harm associated with drug 
dependence. (Available at: http://eur-lex.europa.eu/LexUriServ/site/en/com/007/com007_0199en01.pdf).
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EMCDDA in 004 and 005 (6), where data collection routines and monitoring tools used in different 
European countries had been analysed and ways to obtain a more reliable overview of levels of service 
provision and utilisation in Europe been discussed. The meetings showed that a range of data were 
collected but remained at the level of the agency or sometimes at city or regional level, were often not 
accessible to decision makers at national levels, and that data could rarely be compared across serv-
ices or between countries. Research on harm reduction service delivery was limited, and the few avail-
able studies and analyses concentrated on local service evaluation or planning. There was a general 
lack of information on the clients using low-threshold harm reduction agencies: the use of client-based 
monitoring systems that allow the collection of data according to the European standard protocol was 
rare.  
The project to develop a European standardised data collection protocol started in September 005 
under the umbrella of the Correlation network. The project was carried out by a joint expert group, 
chaired by the EMCDDA, bringing together experts from Catalonia, France, Hungary, Ireland, Slovenia, 
Norway and the Ukraine.
1.3 Objectives and activities of the project
The overall goal of the project was ‘to contribute to increasing reliability and comparability of informa-
tion on harm reduction service provision in Europe’ through the development a draft European protocol 
for standardised annual reporting. This should cover service delivery, structure and functioning of agen-
cies delivering harm reduction services. The protocol should be evaluated by specialist harm reduction 
agencies in different countries (see the logical framework in Table 1 below).
 
Activities of the group included: the definition of the objectives of such documentation with regard to 
information needs at the levels of the agency, and at local, national and EU levels; the collection and 
compilation of already existing questionnaires and other tools used by low-threshold agencies in EU 
Member States; the assessment of the items covered and the analysis of the structure of the tools; the 
selection of core-services, and the drafting of a standard protocol for the documentation of services, 
and of a technical manual with glossary.
6  Meetings were held in December 004 and in June 005 and addressed the topics: ‘Data collection at 
Low-threshold services for Drug Users: Tools, Quality and Coverage’ and ‘Data collection at low-threshold agen-
cies: increasing availability and quality of information at European level”.
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Table 1: Logframe matrix 
Project description Indicators Means of verifica-
tion (MOVs)
Assumptions
1. Goal
To contribute to increas-
ing the reliability and 
comparability of infor-
mation on low-threshold 
harm reduction service 
provision in Europe. 
10. Indicators
European protocol 
for standardised data 
collection on provi-
sion and utilisation 
of harm reduction 
services 
11. MOVs
Information collected 
with the European pro-
tocol is included in the 
Report on the evalu-
ation of the EU Drug 
Strategy 005 - 01
9. Assumptions
Harm reduction 
remains among 
the main objectives 
of the second EU 
Drugs Action Plan 
(009-01)
. Purpose
1. To develop a draft Eu-
ropean data collection 
protocol for standard-
ised annual reporting of 
harm reduction service 
delivery at low-threshold 
agencies as well as on 
structure and func-
tioning of the agency, 
number of clients and/or 
of contacts 
. To evaluate the draft 
protocol indifferent Euro-
pean countries
3. To revise and pro-
duce a final European 
protocol
1. Indicators
1. Draft protocol in 
English language, in-
cluding questionnaire 
on service provision, 
utilisation, clients and 
the agency itself as 
well as a glossary 
and manual are made 
available before ex-
pert meeting Spring 
006
. Pilot test of the 
protocol is con-
ducted in a number 
of different Euro-
pean countries (exact 
number depends on 
resources)
3. Tested version 
of a European data 
collection protocol 
is available at Final 
Conference of the 
Project
13. MOVs
1. Standardised activ-
ity reports from small 
and big low-threshold 
agencies from differ-
ent countries (exact 
number depends on 
resources), testing the 
protocol 
. Report on pilot study 
on Correlation network 
website at time of 
Correlation Conference 
(007)
3. Conference report, 
protocol uploaded in 
Correlation website at 
end of project
8. Assumptions
1. English is accept-
able as reporting 
language across 
European agencies./ 
or there are different 
language versions 
available (resource-
implications)
. Standardised 
reporting tool (draft) 
has been made 
known and acces-
sible to potential 
candidates for pilot 
study
3. Sufficient number 
of agencies have 
been motivated to 
participate in pilot 
study, representative 
sample of small and 
larger agencies.
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3. Outputs
1. Draft data collection 
protocol (form, glossary 
and manual) for pilot test
. Final data collec-
tion protocol in English 
language
14. Indicators
See outputs
15. MOVs
1. Meeting report data 
report group, January 
006 
. Progress report 
presented at expert 
meeting Spring 006
3. Final data collection 
protocol presented at 
Final Conference Cor-
relation Project Autumn 
007 - Report on Con-
ference, Final project 
report Correlation
7. Assumptions
1. Low fluctuation 
among working 
group members 
throughout the 
project duration
. Working group 
members have 
agreement with 
their employers to 
participate and take 
over tasks in the 
project (they have 
reserved working 
time and can use 
e-mail, internet and 
telephone facilities at 
workplace)
3. Regular expert 
meetings are held
4. Active coop-
eration of other 
Correlation network 
members is obtained 
and participation in 
pilot test phase is 
sufficient
4. Activities
1. To collect and compile already existing data collection tools used by low-threshold agencies to 
report on harm reduction services
. To draw up an item list and develop a template for a questionnaire (incl. glossary and technical 
instructions)
3. To conduct a pilot test in selected services in different countries and evaluate the results 
4. To finalise the protocol according to the results of the pilot phase 
The expert group held four meetings: in September 005 (Egmond aan Zee) the logical framework for 
the work on the data collection protocol was developed and the work plan drawn up; in January 006 
(Barcelona), results of the analysis of data collection tools were presented and discussed and core-
services identified; in March 006 (during the nd Correlation Network meeting in Krakow), the first 
draft list of services  was developed, and a discussion of data collection methodologies took place. 
Furthermore, the technical manual and necessary instructions and definitions were discussed. Finally, 
in a meeting in July 006 (Dublin), a first draft of the protocol was discussed and the selection of core-
services finalised. 
The field test version of the protocol was finalised in May 007 and the pilot test of the agency 
inventory carried out between in Spring - Summer 007. Preliminary outcomes of the field test were 
presented In the Correlation Conference in September 007 and a second field test on monitoring of 
core-services was planned, which took place during the Autumn. The project results were analysed 
and written up in December 007 and January  008. 
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. The data collection protocol
.1 Overview
The protocol consists of the agency inventory and of a technical manual providing instructions and 
definitions for its use. It also contains a list of core-services and a description of different approaches 
for carrying out an ongoing monitoring of the delivery of these core-services to drug users.
. The agency inventory
The inventory describes the general type and profile of the agency, its scope of service provision, staff-
ing, management and functioning. If implemented at national scale (either in all target agencies or in a 
representative sample), the results could be used to characterise the scope of national harm reduction 
activities and the geographical distribution of agencies. 
It is presented in six sections.  Section A records the administrative, contact details for the agency and 
its parent organisation and the operating hours for the different facilities provided.  Section B contains 
questions about the population that the agency targets, and about the characteristics of the clientele 
it serves.  Section C helps to describe which type of staff and volunteers work for the agency and how 
they are trained. Section D contains a comprehensive list of facilities and services of harm reduction 
agencies where those that the agency de-facto delivers should be indicated. Section E addresses 
quality standards and management issues as well as the funding.  Section F is intended to help docu-
ment new phenomena in relation to drug use.    
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.3 Selected core-services
The working group selected 18 (16 + ) core-services representing the different fields of activity, which 
are listed in Table  below. Experts suggested to collect data on the delivery of these core-services 
as indicators of the overall level of service provision. Monitoring should be on an ongoing basis and 
results reported yearly.
Table 2. List of selected core services
1   Syringes distributed
   Syringes returned
3   Male condoms distributed
4   Hepatitis B vaccination
5   Infectious disease counselling episodes that inform about testing
6   Diagnostic testing of HIV infection
7   Diagnostic testing of HBV infection
8   Diagnostic testing of HCV infection
9    Woundcare treatments
10  Social care provision
11  Psychological care provision
1  Referral to drug treatment services
13  Referral to social services
14  Referral to medical services
15 Opioid overdose interventions
16 Stimulant overdose interventions (amended after field test)
Core services only for agencies with Drug consumption rooms:
17 Supervised injecting drug consumptions
18 Spervised non-injecting drug consumptions (amended after field test)
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3. The field test (text provided by RIDS, Budapest)
The field test covered the testing of the agency inventory and the services-based data collection sheet. 
3.1 Objectives and target agencies of field test
Objectives
The main objective of the filed test was to address the comprehensiveness and relevance of the 
‘agency inventory’ for documenting service provision and the feasibility of the services-based data col-
lection method to monitor the utilisation of core-services.
Target agencies
The field test was implemented in specialist agencies that
•	 provide low threshold drug, medical or psychosocial services to current drug users and in   
 addition
•	 distribute sterile drug using equipment to current drug users (have needle and syringe pro  
 gramme, NSP).
  
Examples of such specialist agencies included: 
•	 low threshold / ‘drop-in’ centres for drug users, 
•	 drug consumption facilities, 
•	 open health facilities for current drug users,
•	 ‘street-hospitals’, outreach agencies that provide care, advice and hygienic drug use
•	 equipment in street settings
•	 mobile units
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3. Data collection procedures
Sample and sampling methods
Contacts of Correlation Network were used to collect participants for the pilot test on voluntary basis. 
A total of 15 agencies undertook to participate on voluntary basis from 8 European countries and 
one agency volunteered from Iran. The sample was not representative of the European harm reduc-
tion agencies, however, this was not the main objective. An effort was made to involve agencies from 
different parts of Europe to partly ensure geographical and cultural heterogeneity (for agencies that 
participated, please see 3.3).   
Monitoring data collection  
During the field test, either the manager of the agency or a staff member of the participating agency 
completed the agency inventory and the services-based data collection sheet as well as a specifically 
developed questionnaire to evaluate the two data collection tools. The inventory and the evaluation 
sheets were in English. The tools for Catalonian agencies were translated into their native language. 
The rest of the agencies undertook to use the English versions of the inventory and the evaluation 
sheets.  
RIDS was responsible for monitoring the overall data collection procedure, members of the research 
group were also assigned to the participating agencies as supporting partner during the implementa-
tion of the field test. This basically included translation, consultation and the collection of the tools. 
Data processing
The completed agency inventories and evaluation sheets were coded into a database which was then 
transferred into SPSS. 
Two approaches were considered when analysing the data.
1. A quantitative approach was used to analyse agency inventory data. SPSS was used to run 
frequencies of each item in the agency inventory. The main aim was to monitor missing data, which 
allowed drawing conclusions particularly about the possible reasons for the lack or difficulties of data 
provision. Quantitative type of data in the evaluation sheets were also analysed with SPSS (closed-
questions, ratings).
. A qualitative approach was used to analyse open-ended questions in the evaluation sheets. Here a 
more theoretical aspect was taken into account. Answers to open-ended questions were categorized 
according to the type of problem that comments referred to.
The agency inventory was modified and finalised on the basis of the results of data analysis.
Agencies involved:
• Initiative for Health Foundation, Sofia, Bulgaria
• Drugprevention Foundation, Budapest, Hungary
• Krakowskie Towarzystwo Pomocy Uzaleznionym, Krakow, Poland
• Verein Wiener Sozialprojekte (Ganslwirt and Streetwork), Vienna, Austria
• Persepolis NGO, Tehran, Iran
• APDES – Agência Piaget para o desenvolvimento, Porto, Portugal
• Centro Social de Paramos - Espinho, Portugal
• Adeima, Guifões - Matosinhos, Portugal
• Red Cross of Tarragona 
• AEC-GRIS (Grup de reinserció i inserció social) of Barcelona 
• Associació pel Benestar i el Desenvolupament of Barcelona (community intervention and   
 mobile unit, and Baluard drug consumption room)
• Fundació Mercè Fontanilles of Lleida 
• CAS Vall d’Hebron of Barcelona
• Espoir Goutte d’or, Paris, France
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3.3 Results
The main results of the pilot test of the agency inventory and the services-based data collection sheet 
were on the basis of the administered inventory and the services-based sheet and the related evalua-
tion questionnaires. 
Summary
On the basis of the analysis of the results of the pilot test, it can be hypothesised that data provision 
difficulties, which may manifest in missing data, partial, less reliable or estimated data, may be ac-
counted for
• lack or incompleteness of definition of items and that of the context (which may also result in   
 difficulties interpreting questions and items)
• problems arising from the complexity of services and the location of service provision (i.e. 
 certain items in the inventory can not fully cover the complexity and particular nature of 
 services provided by the agency)   
• the lack of or limited data collection at the agency
• the lack or shortage of time to administer the inventory 
• unclear or less clear instructions
• technical problems (difficulties with excel, arrangement of items)
Overall evaluation
Agencies were also invited to provide their overall feedback on the agency inventory as well as the 
clarity of the technical manual. Some basic background data was also collected on the pilot testing 
agencies.
Discussion
Results of the pilot test of the services-based data collection method suggest that the 15 core items 
can be good indicators not only to describe an agency’s service provision profile but to evaluate its 
own activity. The information collected from these core items are good basis to present what these 
agencies do and how effective and active they are. 
The results also suggest that reliable data can be collected on a number of core items: this is particu-
larly true for syringe-related data, male condom distribution, hepatitis B vaccination, woundcare and 
social care. At the same time, certain items are not or less accessible or simply difficult to provide, 
particularly infectious counselling and blood-born test related data (VCT, HBV and HCV tests). It would 
be interesting to see whether these tests are part of a general health service and education in other 
countries as well. If this is the case, services-based data on these items would be difficult to collect. 
Further tests in other countries are required to better see data provision quality. As the results of the pi-
lot test may reflect characteristics of agencies in one region, the results of the test must be interpreted 
with caution. 
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Part II
Data Collection Protocol 
for Specialist 
Harm Reduction Agencies
Final version 3 March 008
 
Section A - Administrative information
Important note: Please consult the technical manual for details and definitions.
Q1. General information on contact person for the Agency Inventory
a. Contact person for this agency inventory ___________________________________
b. E-mail address of contact person _________________________________________
c. Phone (Country code, area code, number)  _________________________________
d. Person(s) filling in the inventory, if different from contact person _________________
_________________________________________________________________________
e. Date this inventory was completed /updated  ____ (day) ____ (month)  ______ (year)
Comments: _____________________________________________________________
_________________________________________________________________________
Q2. Parent organisation of the agency     
a. Name of parent organisation ______________________________________________ 
b. City/town (where headquarter is based) _____________________________________
c. Country ________________________________________________________________
d. Status of parent organisation 
   d.1 Government
   d. Non-government not for profit   
   d.3 Non-government for profit  
   d.4 Other  If ‘Other’, please specify: ________________________________________
_________________________________________________________________________
 e. Web address parent organisation _________________________________________
Comments: _____________________________________________________________
_________________________________________________________________________
Q3. Agency  details                                            
a. Name (or title) of agency _________________________________________________
b. Street  _________________________________________________________________
c. Postcode & City / Town _________________________________________________
d. Country _______________________________________________________________
e. Status of agency (if not linked to any parent organisation or if different status) 
   e.1 Government      
 3
   e. Non-government not for profit   
   e.3 Non-government for profit  
   e.4 Other  If ‘Other’, please specify: ______________________________________
f. Web address agency  ______________________________________________
g. Year agency opened __________________________________________________
Comments: ___________________________________________________________
Q4.General agency type (choose one or more)    
a. Social service provider       
b. Low threshold health service provider   
c. Drug consumption facility       
d. Outreach work 
e. Low-threshold substitution provider: prescribing or/ and dispensing 
f. Other type(s) - please specify: ___________________________________________ 
_______________________________________________________________________
_______________________________________________________________________
Comments: ___________________________________________________________
_______________________________________________________________________
Please indicate all types of needle and syringe provision of your agency:  
g.  Fixed location                         
h.  Mobile (van, bus)   
i. Streetworker outreach 
j. Other type of NSP, specify below:      
_______________________________________________________________________
Comments: ___________________________________________________________
_______________________________________________________________________
Q5. Total opening hours and operating hours of specific agency facilities
a. Total current opening hours for clients of your agency  per week ________ hours
b. …of which ________ hours are in the evening/night (between 8 pm and 8 am)
c. …of which ________ hours are on Saturdays or Sundays
d. Indicate on which days your agency is closed:  
Monday  Tuesday  Wednesday  Thursday  Friday  Saturday  Sunday     
    
e. Total current operating hours per week of selected facilities listed below:
NSP  ______   Social care facilities ______ 
Street outreach work  ______   Medical care facilities ______ 
Drug consumption facility  ______
f. Has there been a major expansion or reduction (of more than 0%) in current operating hours com-
pared to last calendar year?
Expansion:     Yes  No                          Reduction:       Yes  No 
Comments: _____________________________________________________________
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Section B - Target populations and data collection system
Important note: Please consult the technical manual for details and definitions.
Q6. Geographical location of agency (choose one)
a. Inner city      b. Other urban      c. Rural        d. Other, specify below  
Comments: ____________________________________________________________________________
________________________________________________________________________________________
Q7. Type of local drug scene (choose one main type)
a. Open/concentrated      b. Dispersed      c. Hidden    d.Other, specify below  
Comments: ____________________________________________________________________________
________________________________________________________________________________________
Q8. Specific target populations of the agency (choose one or more)
a. Opiate users   b. Cocaine & stimulant users 
c. Imprisoned drug users    d. Adolescent drug users   
e. Homeless people    f. Female drug users.   
g. Migrants     h. Minority ethnic groups   
i. Men who have sex with men    j. Sex workers (m/f)    
k. Other main target population(s):____________________________________
________________________________________________________________________
Comments: ____________________________________________________________________________
________________________________________________________________________________________
Q9. Data collection system of the agency (for definitions see manual)
a. Services-based     b. Contact-based     c. Client-based   
d. Mixed systems, or other data collection system   
Please describe briefly below:
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
Comments: ____________________________________________________________________________
________________________________________________________________________________________
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Client profiles in last calendar year
Q10. Profile of client group of the agency (latest completed year)  
a. Year to which these data refer:  ________  
b. Total number of individual clients or estimate: ______ . 
This is an estimation: Yes   No 
c. Percentage female clients or estimate: ______  % . 
This is an estimation: Yes   No   
d. Age range of clients (in % of individual clients per age group):
______ % are younger than 0 
______ % are between 1 and 40
______ % are between 41 and 50
______ % are over 51 
The age distribution above is estimated: Yes   No   
Comments:  ___________________________________________________________________________
How many of your clients are problem drug users? (see definition in the manual)           
    < 10%   11%-50%   51%-90%    > 91%   
Comments: ____________________________________________________________________________
________________________________________________________________________________________
Q11. Common drugs and routes of administration (RoA)
Name and rank the four drugs that are most commonly used by your clients (not including alcohol or 
tobacco) and indicate their respective main RoA:   
From top to bottom – 
            ▼from most common to least common▼ Injecting Sniffing Smoking   
Other RoA 
Drug: ______________________________________
Drug: ______________________________________
Drug: ______________________________________
Drug: ______________________________________
Drug: ______________________________________
Comments: ____________________________________________________________________________
________________________________________________________________________________________
Provide source / reference of data reported in Q 10 and 11: (e.g. annual statutory report, case statis-
tics, client survey, expert estimate) 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Section C - Staff at the Agency
Important note: Please consult the technical manual for details and definitions.
Q12. Profile of professions 
a. Report how many hours of working time are dedicated to the different tasks per week.    Report 
about the current situation (in the current month):  
Type of work carried out
Approx. hours per week
Paid hours Voluntary hours
Administration and coordination of agency
Social and legal assistance to clients
Psychological counselling or advice to clients
Medical treatment
Services of a nurse
Other - specify type of work: 
Other:  
Other:  
Other: 
b. Does the agency employ current or former drug users as peer educators? 
Yes   No   Please specify: ___________________________________
c. Have there been major increases in staffing levels compared to previous year? 
Yes   No   Please specify: ___________________________________
d. Have there been major decreases in staffing levels compared to previous year? 
Yes   No   Please specify: ___________________________________
Comments: ___________________________________________________________________________
_______________________________________________________________________________________
Q13. Staff training (Please choose either yes or no)     
a. Is the staff training policy of the agency laid down in writing?   Yes   No 
b. Are staff trained in assessing sexual risk taking behaviour and 
providing risk reduction education?     Yes  No 
c. Are staff trained in assessing risky drug using practices and 
providing risk reduction education?      Yes  No    
d. If you answered yes under c., does this training address 
risk behaviour related to non-injecting drug use?     Yes  No 
e. Are staff trained in intervening in drug-related emergencies?   Yes  No 
Comments: ___________________________________________________________________________
_______________________________________________________________________________________
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Q14 Staff safety (Please choose either yes or no)     
a. Are staff systematically informed about the relevance of Hep B 
immunization?          
Yes  No 
b.  Are staff systematically offered Hep B vaccination through the 
agency?
Yes  No 
c. Is there a written Code of Practice (safety statement) on needle 
stick injuries?          
Yes   No 
Comments: ____________________________________________________________________________
_______________________________________________________________________________________
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Section D - Agency services
Important: Please consult definitions & further instructions in the 
technical manual page 21 ff.
Q15. On-site facilities and range of services available (report current situation)
 
Select
Yes or No
If Yes, provide detail  
on services or activities
Do cli-
ents pay 
a fee?
a. Drop in / club / lounge  
     (open access)
Yes   No 
1. Meal (min sandwich) Yes   No Yes   No 
. Leisure activities (games, 
TV)
Yes   No Yes   No 
3. Phone accessible to users Yes   No Yes   No 
4. Internet accessible to 
users
Yes   No Yes   No 
b. Street outreach work Yes   No  
c. Day resting room Yes   No 
 Number of day beds                            __
_________
Yes   No 
d. Night sleeping facilities Yes   No 
 Number of night beds                          __
_________
Yes   No 
e. Personal hygiene Yes   No 
1. Bath/shower room Yes   No Yes   No 
. Laundry Yes   No Yes   No 
3. Clothes distribution Yes   No Yes   No 
4. Condoms (male) Yes   No Yes   No 
f. Services to reduce drug 
use-related health-related 
risks 
Yes   No 
1. Syringes and needles Yes   No Yes   No 
. Alcohol swabs Yes   No Yes   No 
3. Dry swabs Yes   No Yes   No 
4. Info material BBV/ injecting Yes   No Yes   No 
g. Number of NSP provision points:
(enter numbers below      )
5. Citric or ascorbic acid Yes   No Yes   No 
Number of fixed points of syringe provision 
(include all fixed locations serviced by this 
agency) _____
6. Filters Yes   No Yes   No 
7. Sterile mixing containers Yes   No Yes   No 
Number of syringe vending or exchang-
ing machines serviced by agency                     
_____
8. Water (for dissolving, 
flushing) 
Yes   No Yes   No 
9. Sharp bins/ safe disposal 
containers
Yes   No Yes   No 
10. (Aluminium) Foil for drug 
inhalation
Yes   No Yes   No 
11. Crack pipe Yes   No Yes   No 
1. Straws f. intranasal con-
sumption (sniffing)
Yes   No Yes   No 
13. Other - specify:
Yes   No 
14. Other - specify:
Yes   No 
  15. Other - specify:      
                                Yes   No 
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 h. Consumption room Yes   No 
Number of places injection room                         
 ___________
Number of places smoking / inhaling room                 
___________
i. Prison outreach work Yes   No 
  Number of prisons regularly reached                       
__________
j. Accompanied referrals Yes   No  
k. Follow-up of referrals   Yes    No
Comments:____________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Q16. Social care: 
Specify below range of services available, report current situation.
Select
Yes or No
Do 
clients 
pay a 
fee?
a. Basic social needs assessment Yes   No Yes   No 
b. Legal issues advice Yes   No Yes   No 
c. Shelter / housing advice Yes   No Yes   No 
d. Social benefits advices / financial assistance / debts management Yes   No Yes   No 
e. Assistance to obtain or retrieve personal documentation (e.g. health in-
surance card, social benefit documentation, driving license, identity card)
Yes   No Yes   No 
f. Employment advice/job finding Yes   No Yes   No 
g. Brief information on health, social or legal issues and referral Yes   No Yes   No 
h. Structured day employment (day job – mediated employment) Yes   No Yes   No 
i. Parenting advice and support Yes   No Yes   No 
j. Other social care, specify: Yes   No Yes   No 
k. Other social care, specify: Yes   No Yes   No 
l. Other social care, specify: Yes   No Yes   No 
Comments:____________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
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Q17. Crisis intervention, counselling and other structured psychological care interventions 
Specify below range of services available, report current situa-
tion.
Select
Yes or 
No
Do cli-
ents pay 
a fee?
a. Crisis intervention Yes   No Yes   No 
b. Counselling, brief interventions / motivational interviewing Yes   No Yes   No 
c. Case management Yes   No Yes   No 
d. Group work Yes   No Yes   No 
e. Self-help groups Yes   No Yes   No 
f. Other interventions, specify: Yes   No Yes   No 
g. Other interventions, specify: Yes   No Yes   No 
h. Other interventions, specify: Yes   No Yes   No 
Comments:  _____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
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Q18. Medical / nursing / paramedical care:
Specify below range of services available, report current situation.
Select
Yes or 
No
Do cli-
ents pay 
a fee?
a. Basic health assessment Yes   No Yes   No 
b. Assessment of drug use related risk practices Yes   No Yes   No 
c. Assessment of sexual risk practices Yes   No Yes   No 
d. Overdose (emergency) intervention Yes   No Yes   No 
e. Wound management Yes   No Yes   No 
f.  STI clinic (screening and treatment) Yes   No Yes   No 
g.  Dentist/dental care Yes   No Yes   No 
h.  Gynaecologist / well-woman clinic / family planning service Yes   No Yes   No 
i. Pregnancy test Yes   No Yes   No 
j. DOT, management of medication for HAART, treatment of TB, hep C Yes   No Yes   No 
k. HIV diagnostic testing Yes   No Yes   No 
l. HCV diagnostic testing Yes   No Yes   No 
m. HBV diagnostic testing Yes   No Yes   No 
n. Hepatitis B vaccination Yes   No Yes   No 
o. Tetanus vaccination Yes   No Yes   No 
p. Prescribing of substitution drugs Yes   No Yes   No 
q. Dispensing of substitution drugs Yes   No Yes   No 
 r. Are clients receiving substitution or other drug dependence treatment at 
the agency registered in (national) drug treatment reporting system? 
Yes   No 
  Specify reporting system / client register: 
Comments: ____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
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Q19. IEC – Information, Education and Communication
 Select
Yes or 
No
IEC subjects addressed
Select
Yes or 
No
a. Agency organises 
IEC – group training 
sessions for drug us-
ers 
Yes   No 
1.  Safer injection Yes   No 
.  Safer sex (incl sexually transm. infections, 
STI)
Yes   No 
3.  Drug overdose prevention Yes   No 
4.  Blood borne viruses (BBV) Yes   No 
5.  Opioid overdose management (incl CPR) Yes   No 
6. Opioid OD management & naloxone distri-
bution
Yes   No 
7.  Stimulant overdose response Yes   No 
b. Agency organises 
IEC - training sessions 
for family members 
and peers
Yes   No 
1.  Safer injection Yes   No 
.  Safer sex (incl. STI) Yes   No 
3.  Drug overdose prevention Yes   No 
4.  Blood borne viruses (BBV) Yes   No 
5.  Opioid overdose management (incl CPR) Yes   No 
6.  Opioid OD management & naloxone 
distribution
Yes   No 
7. Stimulant overdose response Yes   No 
c. Agency dissemi-
nates IEC - materials
Yes   No 
1.  Safer injection Yes   No 
.  Safer sex (incl sexually transm. infections, 
STI)
Yes   No 
3.  Drug overdose prevention Yes   No 
4. Opioid overdose management Yes   No 
5.  Stimulant overdose management Yes   No 
6.  Blood-borne viruses (BBV) Yes   No 
7.  Drug treatment Yes   No 
8.  Safe disposal of syringes Yes   No 
Comments: _____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
 33
Section E - Management
Important note: Please consult the technical manual page 21 ff for details and definitions.
Q20. Is there a written document on exchange of injecting equipment? 
Yes   No 
      If Yes, does this document address the following topics:   
 a. …a maximum number of syringes given out per exchange? 
 Yes   No           If yes, specify how many: _______
 b.  …the promotion of secondary distribution? (peer distribution or collecting equipment for   
 partners or friends)  Yes   No 
  c.  …the promotion of safe disposal ? Yes   No 
  d. …a (lower) age limit for the provision of injecting equipment?  Yes   No 
  If yes, specify minimum age: ______
  e. …the verbal communication of information on prevention of injecting-related health dam      
age to the client? Yes   No 
Please provide detail: _______________________________________________
 _______________________________________________________________________________
f. …the handing out of printed information materials on prevention of injecting-related health 
damage to the client?  Yes   No 
Please provide detail: _______________________________________________
 ________________________________________________________________________________
g. Other topics (specify): ____________________________________________________________
Comments:___________________________________________________________________________
_____________________________________________________________________________________
Q21. Disposal of used injecting equipment  
Are any of the following methods used?    
a. Sharp bins given out to NSP clients                                                                    Yes     No 
b. Clients rewarded (e.g. paid) for safe return                                                          Yes     No 
c. Other (specify): _________________________________________________________________
Comments: _____________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Q22. Is there an initial assessment for new clients?                                                    Yes    No 
Comments: _____________________________________________________________________________
_______________________________________________________________________________________
Q23. Is there a written care plan for individual clients?                                               Yes    No 
Comments: _____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Q24. Criteria for non-admission to premises    
a. No local residence   Yes   No  
b. Under required minimum age  Yes   No  If Yes, indicate which age:                 
c. Exclusion of undocumented migrants  Yes   No 
d. Other (specify): _________________________________________________________________
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Comments: ____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Q25. Is there a written code on drug users rights and responsibilities (patients’ charter)?  
Yes   No  
Comments: _____________________________________________________________________________
________________________________________________________________________________________
Q26. Is there a client association linked to your organisation? Yes   No 
If Yes, please provide name, address and telephone or email contact of organisation: 
_____________________________________________________________________________________ 
_____________________________________________________________________________________ 
Comments: __________________________________________________________________________
________________________________________________________________________________________
Q27. What was the total budget for this agency for the last three financial years? 
Year     Budget (in Euro)   
200.. € ______________________    
200.. € ______________________
200.. € ______________________ = latest completed calendar year
Comments: ____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Q28. What percentage of the agency’s last year budget was contributed by:  
Last completed calendar year: __________ If different: Budgetary year: __________ 
Government grants      ___________%   
Non-government grants      ___________% 
Public fund raising / donations    ___________%  
Client fees or health insurance    ___________% 
From budget of own organisation    ___________% 
Other (specify: ___________________________________) ___________%  
Total should add up to 100%   
Comments: ____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
   
 35
Q29. Is there a systematic evaluation of client satisfaction?  Yes   No 
Comments: ____________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
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Q30. Evaluation of outcomes    
a. Does this agency currently undertake or participate in any internal or external evaluation of 
the harm reduction process or clients’ outcomes?                        Yes       No 
b. If Yes, please specify which evaluation instruments are used: 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
Comments: __________________________________________________________ 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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Section F - Early warning
Important note: Please consult the technical manual page 21 ff for details and definitions.
Q31. Does the agency have an emergency or help phone line or pay for the services of a 
helpline?  
Yes   No 
Comments:  _____________________________________________________________
  
Q32. Does the agency participate in a formal early warning system? Yes   No 
Comments: _____________________________________________________________
  
Q33. During the last 12 months, have you noticed a phenomenon, among drug users living in 
your catchment area, which is new or a significant change to an already known phenomenon, 
namely in the following areas? (Explain why and how the changes appeared. If there are no 
elements to explain it, you can just hypothesise).   
  
a. An unknown product (drug): describe the form (powder, liquid, pill, spray, etc.), colour, presentation 
(paper pack, ball, plastic pack, etc.); mention the different denominations and the content supposed 
under each.
________________________________________________________________________________________
________________________________________________________________________________________
__________________________________________________________________________________________________________
__________________________________________________________________________________________________________
 
b. A new consumer profile among the users of the structure. By new profile, one understands a more or 
less homogeneous group on at least one aspect. This can be the age (adolescent, young people, adults 
between 30 and 40 years, etc), the place of dwelling (suburbs, city, town centre), a cultural characteristic 
(music, religion), the geographical origin (Eastern Europeans, Asians, north Africans etc), the way of life 
(wandering, sedentary, squatters etc), the type of occupation (lorry drivers, mason, restoration, show 
business, etc).   
________________________________________________________________________________________ 
________________________________________________________________________________________
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________
c. A new route of administration, the spreading of a known route or of a combination of drugs. What are 
the expected and the actually felt effects of this administration route or drugs cocktail?  
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________ 
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________________________________________________________________________________________ 
  
d. A new health problem among drug users (OD, abscesses, psychiatric problems, etc.) or the aggrava-
tion of a known problem. What, according to you, is the cause of this?
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________ 
e. A new social problem (e.g. marginalisation, unemployment, poverty, violence, delinquency, etc.) or the 
noticeable aggravation of a known problem and what is it related to.
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________ 
________________________________________________________________________________________
General comments: ____________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
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________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
Many thanks!  
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Annex I: Technical Manual
Agency: Please note that the term ‘agency’ is used here to name a structure (low-threshold center, 
outpatient unit, day-care center, emergency shelter, drugs ‘project’)  that employs staff to enter in 
direct contact with drug users and provides harm reduction services to them. 
Service: The term ‘service’ is used to describe the concrete activities that are carried out by such an 
agency. For example exchanging syringes or counselling clients are ‘services’. 
An agency is a service provider. For example: the delivery of clean syringes is a service that a staff 
member employed at an agency provides to a client.
The agency inventory was developed for specialist agencies that offer low-threshold drug dependence 
and/or medical and/or psychosocial services to current problem drug users including a needle and 
syringe programme.
Section A: Administrative information
Q1 General information on contact person 
The agency inventory instrument and data tables should be filled out by the manager of the agency or 
another staff member specifically assigned to this task, who should ideally also be the contact person 
in case questions arise or clarifications are needed by the data collecting body. A staff member of the 
parent organisation can also fill out the inventory/tables. The full contact details should be indicated. 
Q2  Parent organisation of the agency
This question applies only to agencies that are in administrative terms part of a larger “parent” organi-
sation. A parent organisation is the organisation that the service/agency belongs to, for example an 
larger non-governmental organisations, religious communities/churches, enterprises, or public health 
structures which run more than one agency. If your agency is self-contained, do not enter data here. 
Please ensure that details are correct and up to date. If a parent organisation runs several agencies 
that meet the criteria for the target agency, each of those should fill out the agency inventory instru-
ment,
Q3 Agency details
Please fill out the information on your agency and ensure that details are correct and up to date. 
Q4  General agency type 
Tick one or more that best describe your agency, according to the services it provides to current (non-
abstinent) drug users:
a. Social service provider
Agency that provides support on accommodation, employment, social benefits to current drug 
users.
b. Low threshold health service provider
Specialised agency that provides health care services to current drug users, including a basic 
health assessment, basic medical and nursing care, wound care and health education. There 
must be either a medical doctor or a nurse employed, or both. Some special provisions must 
be in place aimed at facilitating the access of current users to the provision of such services, 
e.g. location near street drug markets, no appointments required, extended opening hours dur-
ing nights, etc.
c. Drug consumption facility
Drug consumption facilities also called drug consumption rooms, are official facilities where 
people can take illegal drugs under supervision by staff, who also gives advice on risks, edu-
cates clients about safer drug use techniques and provides emergency help in case of over-
dose or other adverse reactions. 
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d. Outreach work 
Outreach work has been defined as “a community-oriented activity undertaken in order to con-
tact individuals or groups from particular target populations, who are not effectively contacted 
or reached by existing services or through traditional health education channels” (Hartnoll R.L., 
et al. (1990), A survey of HIV outreach intervention in the United Kingdom, London: University 
of London, Birbeck College). 
Three different working methods in outreach work have been distinguished: detached, domicili-
ary and peripatetic. Detached outreach, when agency outreach workers meet clients on the 
street to provide injecting equipment, information, referral or other services, is by far the most 
common. It is called domiciliary outreach when the outreach workers go to the home of clients, 
and the term peripatetic outreach describes that outreach workers of an agency go to other 
premises where clients can be found, in particular prisons or hospitals. 
e. Low threshold substitution provider (prescribing and/or dispensing)
A low threshold substitution provider is an agency that is involved in prescribing drug substi-
tution medication to drug users by accredited staff, or/and by dispensing the medication to 
clients that are in treatment at another agency. Some special provisions must be in place aimed 
at facilitating the access of current users to the provision of such services, e.g. location near 
street drug markets, no appointments required, extended opening hours during nights, etc.
f. Other type
Needle and syringe programme - NSP
Needle and syringe programme – sterile syringes and other equipment for hygienic drug injecting are 
distributed, exchanged against used ones, or sold and usually information about injecting risks, tech-
niques and hygiene is provided at the same time to clients receiving the items.  
If your agency provides a number of service types, please indicate all available types
g. Fixed NSPs
Fixed needle and syringe programmes are those located at a fixed address in a formal building.
h. mobile NSPs
A mobile NSP is run from a specially equipped mobile unit (van/bus) that attends different loca-
tions on a regular basis (daily or weekly) 
i. Street outreach 
This category includes detached outreach by agency staff but also domiciliary outreach – see 
definition of outreach above. Streetworkers carry drug using equipment and distribute to drug 
users in the street or to drug users’ residence.
j. Other type of NSP
Please describe which other type.
Q5. Total opening hours and operating hours of specific agency facilities 
Opening hours for clients
Please record the total number of hours during which any facility within your agency is open for clients 
during one week. Indicate the current situation (weekly opening house in the current month). For a 
permanently open facility this would be 168 hours. 
Total operating hours per week of selected facilities/services
Please report during how many weekly hours any of these specific facilities are open / services are 
offered to clients. Data should only be supplied on those facilities/services that are provided by your 
agency. For street outreach work count only the time during which delivery of services takes place, not 
the time the workers need to reach the outreach location. Count the time of outreach service provision 
regardless of size of outreach teams (do not add up man-hours). 
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Section B: Target populations and data collection system
Q6. Geographical location of agency
Please classify the geographical setting of your agency using the guidelines below. Chose one setting 
according to definitions below.
If in doubt, choose setting where agency mostly provides its services.
a. An inner city area is the central area of a major city.
b. Other urban areas are non-central areas of a major city and other cities
c. A rural area is a less densely populated area with an agricultural influence
Q7. Type of local drug scene 
Please classify the main type of drug scene that is of most relevance for your agency in terms of 
service provision, according to definitions below (Source: R. Bless, D.J. Korf, M. Freeman : Open drug 
scenes: A cross-national comparison of concepts and urban strategies, Eur Addict Res 1995; 1: 18-
138). Choose only one option.
a. Concentrated open Scene : “Large permanent concentrations of drug users at a focal 
point, often an inner city area characterised by entertainment industries and/or a major trans-
port node. Identified by the general public and the authorities as an open scene. High level of 
confrontation by the presence of obvious drug users and occurrence of public use of drugs
b. Dispersed open scene : “Small concentration of users at various places within the urban 
area, ranging from inner city to transport nodes to degraded residential districts. Individual 
scene are often mobile and do not occur all day.” 
c. Hidden scene : “No visible concentrations of users. There is a public awareness of local 
drug scene however, usually without distinction between hard and soft drugs. Actual confronta-
tion is limited to residential premises where users and dealers live or to the relics of drug use, 
like discarded needles, in public places.”
Q8. Specific target population(s ) of the agency
Please indicate one or more target population(s) which the services provided by your agency are aimed 
at.
Q9. Data collection system of the agency
Indicate which of the following reflects best the general design of data collection, or describe other 
system.
a. Services-based data collection
Levels of service provision can be recorded in three different ways: based on services, con-
tacts or clients. In the case of ‘services-based’ recording, the agency collects information 
on total number of times a service was provided. E.g. number of syringes, condoms or other 
items given out, number of medical, psychological or referral services performed. No data on 
the users of the services are collected. The method helps to monitor the use of resources and 
provides a general overview of ‘turnover’, but it does not allow to distinguish how many and 
what type of clients have been reached. 
b. Contact-based data collection
We have defined as ‘contact-based’ recording a limited amount of information about the 
service users is recorded each time a service provision contact takes place. In our pilot study 
we used the three variables gender, age group, drug injector/ non-injector. The client informa-
tion is assessed and recorded by the agency staff; clients do not have to provide any personal 
information, no identification is required to obtain the service. This approach is more complex 
and work intensive than services-based recording, as it requires the assessment of the three 
variables by staff at each time a service is delivered. However, the status of injector/non-injector 
can be difficult to determine which results in missing data. This method allows the monitoring 
of changing client characteristics, and the generation of basic statistical analyses of service 
delivery for various client groups. It is a feasible method of data collection even if the service 
provision contacts between staff and clients are of short duration, or take place in outreach/
street settings.
c. Client-based data collection
Finally, ‘client-based’ recording of service provision requires that the agency has a system in 
place to identify its individual clients and keeps records of their socio-demographic and drug 
 43
use profiles (including the TDI dataset). There is a client-card system or other procedure in 
place to make sure that individual clients are easily identified each time a service is provided to 
them. Double-counting of persons within the agency, between institutions in the same location 
and ideally also at inter-institutional national level is herewith avoided or at least limited (nation-
wide treatment client identifiers are however rare in the EU). There are also solutions where 
individual client codes are created each time a service is used. Client-based systems are easier 
to implement when electronic means (ID cards) are used and when the agency has a compu-
ter-network that links the various service provision areas to a central database. The system 
provides excellent monitoring possibilities to the agency. Detailed statistical analyses of service 
demand can be carried out and patterns of service use be analyses, at least within the agency 
but also in a wider network of agencies that uses the same client ID. While this model delivers 
the most relevant data, it is rarely implemented for reasons of data protection and problems 
related to lack of feasibility in typical harm reduction settings like ‘drop-in’ or streetwork. 
The pilot study has explored some of these data collection systems. It is described in chapter 3 of the 
final report.
Q10. Profile of client group
Only applicable if the agency collects data number, gender-ratio and age range and drug use profile of 
individual clients served by the agency. The reporting period for questions 10 and 11 is from 1 January 
to 31 December of the last calendar year for which data are available. Enter the year to which these 
data refer.
Q11. Common drugs and routes of administration (RoA)
Indicate respective main route(s) of administration for those four drugs that have been most com-
monly reported as problem drug among your clientele during the reporting year. Excluding alcohol and 
tobacco. Sniffing = intranasal; smoking = pulmonary (includes chasing the dragon).
Problem drug use
Problem drug use is defined for EMCDDA purposes as ‘injecting drug use or long duration 
or regular use of opiates, cocaine and/or amphetamines’. This definition specifically includes 
regular or long-term use of prescribed opiates such as methadone but does not include their 
rare or irregular use nor the use of ecstasy or cannabis. 
Section C: Staff at the agency
Q12. Profile of professions
Please complete during how many paid and voluntary hours the different professional services are 
provided at the agency per week. Add up hours of all staff members that carry out the type of work. 
Report about the situation in the current month. 
If there is no voluntary work, put “n.a.” (not applicable). Calculate weekly paid hours as 5% of paid 
working hours per month. If any data are unknown, put “not known”. 
Indicate if current or former drug users are employed at the agency as peer educators, specify their 
tasks.
Indicate if there have been major de- or increases in staffing levels compared to previous year. 
Q13. Staff training
This question is about training provided to the agency’s staff. Please refer to the definitions below to 
ensure a common understanding of the questions.  
a. Staff training policy
The minimum requirement to indicate that there is a staff training policy is the existence of a 
written training protocol listing training topics that are relevant to the work of the agency, or the 
definition of a minimum number of hours of training to be provided to each agency worker per 
year, or a similar formal and written commitment of the agency to commit funds for keeping 
professional competence of staff on a regular basis up-to-date. 
b. Assessment of sexual risk taking practice and education on risk reduction
Some or all staff of the agency is trained to explore the current sexual practices and related risk 
taking of clients, their knowledge of sexually transmitted infections, of interaction between drug 
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use and risk taking, and their awareness of local services that provide sexual health services. 
Staff knows how to explore clients’ attitudes towards condom use and other preventive meas-
ures, and management of risk (post-exposure prophylaxis).
c. & d. Assessment of drug use related risk taking practice and education on risk reduction
Some or all staff of the agency is trained to carry out an assessment of risk taking practices. 
Staff is trained to explore clients’ current drug use, their current and past injecting practice (in-
cluding skills and sharing practices), experience of overdose and overdose management skills, 
access to and interest in blood-borne viral testing, and  uptake of hepatitis A & B vaccine. 
e. Drug-related emergency interventions
Some or all staff of the agency is trained to intervene in case of overdose or other drug-related 
emergency. Such training should include the knowledge on typical risk factors (especially drug 
interactions, effects of central nervous system depressant drugs including alcohol); overdose 
risk settings and situations; assessment of clients’ personal risk profiles (previous overdose 
experience, depressive symptoms, previous suicide attempts, current suicidal ideation). Staff 
should also be trained in recognising overdose signs ans symptoms and responding to manage 
overdose. For an opiate overdose, the appropriate response includes laying the person in a 
lateral position (on their side / recovery position), loosening tight clothing, ensuring their airway 
is clear, administering oxygen, naloxone if available, calling the emergency services. Manual 
cardio pulmonary resuscitation skills may also be trained.  
Q14. Staff safety
Under b. the costs of the vaccination would be borne by the agency.
c. Code of practice on needle stick injuries
Written guidelines, outlining all steps to be taken to prevent and minimise the risk of needle stick inju-
ries and to reduce their consequences (especially among NSP workers).
Section D Agency services  
Q 15. On-site facilities and range of services available
It is important provide an objective picture of services that drug users can obtain/benefit from through 
your agency. Report about the availability of services and facilities as it is during the current month. Do 
not report services that have been available in the past but are no longer available now – and do not 
report about services that are planned to become available in the future. You should however indicate 
services and facilities that your agency offers, even if they are not being used.
Please read the definitions and further explanations below. Read the table row by row and, following 
the instructions in the column heading, and answer the questions. Indicate for each service is its avail-
able and if the clients have to pay a fee to receive it. 
g. Number of NSP provision points, vending machines
Counted should be all physically distinct locations where your agency provides syringes and 
other injecting equipment for free, against payment or in exchange against used ones, usually 
together with information on injecting risks, techniques and hygiene. These can be other health 
services, hospital wards, or prisons (via peripatetic outreach). If the agency has no fixed NSP 
locations and does not service vending machines write “n.a.” (not applicable). If the information 
is unknown write “not known”.
f.2 Alcohol swabs and dry swabs
Alcohol swabs should be used to clean the skin before the injection. After the injection, dry 
cotton wipes/pads should be used, to cover the injecting point and protect it. Alcohol swabs 
should not be used after injection, because the alcohol prevents the injection wound from clos-
ing. Paraphernalia kits should contain both types of swabs.
j. Accompanied referral
The term ‘accompanied referral’ can be defined as liaising between the person requiring help, 
information or treatment and the person providing such assistance. The person brokering the 
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liaison between the service provider and the client may introduce the client to the provider face 
to face or follow a written protocol (including follow-up) that ensures the client receives the help 
required.  
k. Follow up of referrals
The term referral is defined as directing clients to a source for help or information at another 
agency (this can also be another branch of the own parent organization) . There is an agency 
written -or other established- procedure to follow up clients which are being referred to other 
agencies. The follow up is either by phone, electronic mail, letter or other means, including ac-
companiment, and needs the agreement of the client.
Q16. Social care
Describe the range of social assistance that your agency provides, according to the definitions of 
services below.
a. Basic social needs assessment
A systematic assessment of the basic social needs of each client is made, which explores the 
clients current situation regarding housing, economy and social network, including specifically 
his/her access to proper food and hygiene. 
b. Legal issues advice 
The agency provides the services of a lawyer free of charge for their clients. The legal advice 
delivered may be related to judicial problems linked to drug use (e.g. dealing, arrest, probation) 
or might concern other social or personal issues (e.g divorce, custody of children, car acci-
dent).
c. Shelter / housing advice 
The agency actively mediates (see * below) permanent or temporary accommodation for drug 
using clients – renting of an independent flat, accommodation in an apartment that belongs 
to the social or health administration or booking /providing overnight accommodation in an 
emergency shelter.
(*) To actively mediate means not only to make written or oral referral or provide information 
about temporary or permanent accommodation or shelter but to engage in a direct and active 
contact with agencies providing such services.
d. Social benefits advices / financial assistance / debts management 
The agency has trained staff that helps drug users to solve their financials problems, including 
assessing eligibility and/or assisting with registration for social benefit payments. This can also 
include help to access credits that facilitate staggered re-payments of personal debts. 
e. Personal documentation assistance (driving license, identity card, health insurance)
The agency systematically helps clients to recover or obtain replacement of personal docu-
ments such as identity card or passport, driving license; and medical or social benefits docu-
ment.
f. Employment advice/job finding 
The agency collects and disseminates on a regular basis information about the local job market 
and provides active job counselling through its own trained staff to support drug users to find a 
permanent or temporary employment. 
g. Brief information on health, social or legal issues and referral 
Used in situation of street outreach, when time only allows short information (not advice) on 
relevant topics, and where referral to competent agencies plays a major role. The term referral 
is defined as directing clients to a source for help or information at another agency (this can 
also be another branch of the own parent organization) .
h. Structured day employment (day job – mediated employment)
The agency regularly provides opportunities for paid work to its clients, on a day-by-day basis 
(different from contractual work or over longer periods)
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i. Parenting advice and support
The agency has trained staff available who actively and systematically address those clients 
who are responsible for the care of one or more underage children, assess their need for 
support and advice with regard to their role as parents, and provide or help to access the 
necessary services. This includes support to parents who use drugs during the antenatal and 
postnatal period.
Q17. Counselling and other interventions 
Support services aiming at reducing drug users’ personal and emotional problems; covers a range of 
different approaches. Staff applying counselling techniques needs to have specific training.
a. Crisis intervention
Intervention by trained staff to manage acute, critical situations (e.g. serious emotional disabili-
ties, paranoid or depressive episodes) in the ‘natural environment’ of the agency [as opposed 
to specific counselling or treatment settings] with the aim of restoring the person to the level of 
psychological functioning before the crisis and at reducing related physical and social harms.
 
b. Counselling, brief interventions / motivational interviewing 
Trained counsellors support individual clients to develop coping strategies or resolve conflicts 
by providing a supportive and non-judgemental atmosphere. Counselling generally deals with 
concrete current life situations, and is a short-term, goal-orientated activity to enhance the 
clients’ own capacities.  
A brief intervention can range from 5-10 minutes of information and advice given to a drug user 
to -3 such sessions. Brief interventions are targeted at drug users who are not yet experienc-
ing major problems from their consumption. They are not designed for dependent drug users. 
The aim of the intervention therefore is to encourage them to reduce their drug consumption to 
sensible limits in order to reduce the risk of future health problems. 
 
Motivational interviewing is a directive, client-centred counselling style for eliciting behaviour 
change. It aims to facilitate and increase a person’s intrinsic motivation to change problematic 
behaviour in a supportive but strategically directed conversation about the person’s use of 
substances and related life events. It also attempts to increase the awareness of patients of the 
health risks they are running and their capacity for doing something about this. The interview is 
normally conducted by staff with specialist training.  
c. Case management
Management of care for a client is assigned to a single person (or small team) who coordinate 
all necessary medical, psychological and social care with the relevant in-house or external 
resources/agencies. Based on a needs assessment and a care plan definition with the client, 
and in collaboration with all service providers, the case manager links clients with appropriate 
providers and resources throughout the continuum of health and human services and care 
settings. The idea behind case management is to enhance access to care and improve the 
continuity and efficiency of services.
 
d. Group counselling, group work
Trained counsellors work with groups of clients in group settings. Important component of the 
work with the group is the exchange of experience between group members, mediated by the 
counsellor.
e. Self-help groups
These are voluntary groups that involve drug users and are facilitated by a layperson (current or 
former drug user). The purpose is to share information and to deal with concerns or problems 
of their members, and to provide mutual support in solving these problems. 
Q18.  Medical / nursing / paramedical care 
a. Basic health assessment
A basic health assessment is carried out by a medical doctor or a nurse and consists of taking 
the history of: drug use, treatment for drug use, risk practices, blood-borne viral testing and 
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status, overdose, other consequences of drug use, and hepatitis B vaccine status.  It includes 
a physical examination and, if necessary, the provision of physical health care advice.  
b. and c. Assessment of drug use related and sexual risk practices 
Clients’ risk practices are assessed by agency staff at defined occasions (e.g. in early phase 
of contact, then repeated in regular intervals) with a view of providing information and skills for 
prevention of harm and reduction of risks.
Assessment of drug use related risk taking practice includes the exploration of clients’ current 
drug use, their current and past injecting practice (including skills and sharing practices), expe-
rience of overdose and overdose management skills, access to and interest in blood-borne viral 
testing, and  uptake of hepatitis A & B vaccine. 
Assessment of sexual risk taking practice includes the exploration of clients sexual practices 
and related risk taking, their knowledge of sexually transmitted infections and prevention, 
awareness of the interaction between drug use and risk taking, and knowledge of available 
sexual health services. 
d. Overdose emergency interventions 
The emergency intervention is provided by trained staff and concern drug users who show 
severely impaired consciousness as a consequence of drug consumption, and to prevent 
overdose morbidity and mortality. In the case of an opiate overdose, the appropriate response 
may include putting the person in the recovery position, loosening tight clothing, ensuring their 
airway is clear, administering oxygen, providing cardio pulmonary resuscitation, administrating 
naloxone if available and necessary, calling the emergency services. 
e. Wound management
Wound management consists of assessing the wound, providing treatment to heal the wound, 
monitoring of progress in relation to healing and advise how to deal with lack of progress. 
f. STI clinic 
STI clinics provide counselling, testing and treatment for Sexually Transmitted Infections (STI’s).  
These infections include HIV, Chlamydia, genital warts, gonorrhoea, hepatitis A or B, herpes 
1 and 11, non-gonococcal urethritis, intestinal parasites, and syphilis. STI clinics may also be 
known as GUM clinics (with reference to the genitourinary tract).  
g. Dentist/dental care 
The agency provides on a regular basis (at least once per week) on-site dental care by a trained 
dental professional (dentist, dental hygienist, dental nurse, dental technician).
h. Gynaecologist / well-woman clinic / family planning service
The agency provides a well woman clinic (see definitions below) on-site care by a medical 
gynaecologist and these services are offered at regular intervals. A well woman clinic provides  
specialised services regarding the diagnosis and treatment of minor gynaecological and sexual 
disorders, and offers advice on related health matters: may include advice on gynaecological 
problems, family planning (often including IUD fitting), cervical smears, breast disease and the 
menopause, emergency contraception. 
i. Pregnancy test
The agency provides an on site (or take home) physiological test to determine wheth-
er a person is pregnant, usually through an early-morning urine sample where the 
presence of human chronic gonadotropin (hCG), the pregnancy hormone, is tested.
j. DOT for HIV, TB, hep C 
The abbreviation DOT stands for directly observed therapy. DOT means that a care worker 
(usually a nurse) manages the medications for the treatment of a specific illness/infection of the 
client, reminds clients to take their medicines, observes the patient taking each drug dose and 
reports any side effects experienced. Relevant illnesses where DOT can be useful for drug us-
ers are HIV, Hepatitis C Virus infection and tuberculosis, as complex combinations of medica-
tions might be required which are difficult to manage under specific characteristics of drug use 
lifestyles or for homeless persons. The category should be answered with ‘yes’ if DOT for at 
least one of these illnesses is provided.
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k. , l. and m. HIV / hepatitis C and B diagnostic testing
The agency provides on-site diagnostic testing of infectious diseases on a voluntary base after 
providing the right information to the client to make an informed decision about having a test or 
not and having their consent. Staff makes sure that pre and post test counselling is offered to 
help the client to cope with the psychological and health implications of the results.
n. Hepatitis vaccination
The category should be ticked if vaccination against Hepatitis B (or A/B) is provided at the 
agency, by medically trained staff. 
o. Tetanus vaccine
Medically trained staff at the agency provides immunization against tetanus (the Td vaccine, T 
vaccine) or short-term protection (use of Tetanus immune globulin, when someone is believed 
to have recently been exposed to the bacteria).
p. Prescribing of substitution drugs
The pharmaceutical drugs used for substitution treatment are prescribed by suitably qualified 
medical practitioners. Includes low-threshold or emergency substitution while waiting for admit-
tance into regular treatment programme.
q. Dispensing of substitution drugs 
The substitution drugs (mainly methadone, buprenorphine) are given out by qualified and 
trained staff at the agency, often on a daily basis. Includes treatment in cooperation with exter-
nal medical practice.
r. Report to the National drug treatment reporting system 
Indicate whether clients receiving drug dependence treatment at the low-threshold agency are 
registered in a national database  / to determine through which mechanism these treatments 
are recorded in national treatment registries.
Q19 IEC
IEC is the abbreviation for “information, education, communication”. Targeted IEC strategies in the 
field of harm reduction may involve organising trainings for different target groups to inform, educate 
and communicate about drug use-related risk and risk management. Indicate if your agency provides 
such trainings for the target groups of drug users and/or for family members and peers and if yes, 
specify the topics of such training. Indicate if your agency disseminates targeted IEC material (flyers, 
info cards, comics, brochures, etc for the target group of current problem drug users) and on which 
specific topics.  
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Section E: Management
Q20. NSP guidance 
Please indicate whether written guidelines for agency staff on NSP practice have been drawn up at 
your agency, and specify the contents further. 
Q21. Disposal of used injecting equipment
Please indicate if the agency provides special sharps containers to clients to take away or rewards 
clients for returning syringes, for example through payment of money or other benefits.
Q22. Clients initial assessment  
Please indicate either yes or no. See definition below.
Initial assessment
An initial assessment is a systematic evaluation of an individual’s needs. The aim of assess-
ment is to identify the requirements of the individual in order to inform decisions about care and 
support. It usually takes the form of one-to-one discussions between the service provider /staff 
member and the individual. The findings of this meeting are documented and form the basis 
for the care plan.  The care plan are the actions that will be taken as a result of the key findings 
during the initial assessment.  
Q23. Care plan
Please indicate either yes or no. See definition below.
A care plan is a structured, often multidisciplinary, and task-oriented individual care pathway 
plan, which details the essential steps in the care of a drug user and describes the expected 
treatment and care course. The care plan involves the translation of the needs, strength and 
risks identified by the assessment into a service response. It is used as a tool to monitor any 
changes in the situation of the client and to keep other relevant professionals aware of these 
changes. (adapted from Models of Care, http://www.nta.nhs.uk/areas/models_of_care/default.
aspx)
Q24. Non-admission 
Indicate the conditions that lead to refusal to enter any of the agency’s premises. Specify other criteria 
if necessary.
Q25. Code on drug users’ rights and responsibilities
Document specifying rights and obligations of the drug users while using the agency’s services. 
Q26. Client association
Is your agency linked to a self-organised formal association of clients (current or former drug users), 
e.g. through voluntary work, joint initiatives, local round-tables or agreements regarding cooperation or 
exchange?
Q27. Budget for last three years
Please provide total amount of funding received to operate the agency in the previous three years, 
indicate which years these are, the latest completed calendar year should be reported.
Q28. Funding sources
Please provide the percentage of funding in the most recent budget that was contributed by the listed 
stakeholders. This is for the most recent completed calendar year, or if different for the latest com-
pleted budgetary year.
Q29. Evaluation of client satisfaction
Please indicate if satisfaction of clients with the agency is measured regularly and by using standard-
ised tools.
 
Q30. Evaluation of outcomes
Please circle either yes or no to part a (see definitions below)
If yes, please write in exact text of the title of the evaluation instruments used
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Section F Early Warning
Q31. Helpline
Please indicate either yes or no.
Helpline
A drugs helpline is a confidential, free telephone service offering non-directive support, informa-
tion, guidance and referral to anyone with a question related to substance use or its conse-
quences. 
Q32. Participation in early warning
Please indicate either yes or no
Early warning system
System to detect new drugs and drug use patterns that could result in increased health risks. 
Addresses new phenomena or problems that came to the attention of staff at the agency. 
Q33 a-e. New trends or substances
Please read the statements for each part of this question carefully and answer each considering the 
instructions.  
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Annex II: Core-services
Annex II provides a list of services which are indicators of the overall level of service provision at the 
agency. Data on the delivery of the core-services should be collected on an ongoing basis. Definitions 
and rules for recording service provision and a description of different approaches to monitoring serv-
ice delivery are provided below.
Table 1. Core-services for monitoring
Core services Rules for recording the provision of the services
1 Syringes distributed Record the number of syringes given out by agency staff. If sy-
ringes are distributed in kits with more than one syringe, the total 
number of syringes should be recorded. Additional needles given 
out separately or in addition to syringes should not be counted.
 Syringes returned Record the number of syringes received back at agency, returned 
to outreach teams or collected by clients or staff. If syringes are 
given back in safe containers, the amount of syringes should 
be estimated according to a method defined beforehand at the 
level of the agency (weight, capacity of container). The estimation 
method should be described in the reporting table.
3 Male condoms distributed Record the number of condoms given out to clients at the 
agency.
4 Hepatitis B vaccination Record the number of individual doses of the vaccine that were 
applied to clients at the agency. All doses should be counted, not 
only the third dose.
5 Counselling on infectious 
disease testing
Record the number of all counselling sessions where clients 
received counseling that included information on relevance of 
diagnostic testing of infectious diseases (drug-related and STI). 
Sessions are recorded regardless of whether they finally resulted 
in carrying out a test for infectious disease(s) or not. Only counsel-
ling sessions that lasted 10 minutes or more and were delivered 
in a one-to-one setting should be recorded.
6 HIV testing Record the number of times clients underwent a blood or saliva 
test  at the agency for any of the three listed viruses, when this 
was done for diagnostic purposes. If several tests are based on 
same sample of body fluid, they should be counted separately. 
Testing for purely epidemiological purposes, when results are not 
communicated to clients, should not be recorded.
7 HBV testing
8 HCV testing
9 Wound care treatments Record the number of times a treatment of any wounds resulting 
directly (e.g. abscesses) or indirectly  (sore feet of homeless drug 
users) from drug use. Multiple wound treatments on the same 
person on the same day are summarised as one wound care 
treatment episode.
10 Social care provision Record the number of times agency staff has provided advice 
and support regarding social issues, e.g. housing, employment, 
legal problems, childcare, parenting, debts: see range of services 
listed under question 16.  Only social care intervention that last 
more than 10 minutes should be counted.
11 Psychological care  provi-
sion 
Number of times structured psychological care (see range of 
services listed under Q 17) was provided by trained agency staff. 
Care episodes should have a minimum duration of 10 minutes 
and be delivered in a one-to-one setting.
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1 Referral to drug treatment 
services
Number of times clients have received referrals to other agencies 
or institutions in order to receive: drug treatment (including to a 
medical doctor for substitution treatment), social assistance (e.g. 
employment office, welfare office), medical consultations (e.g. 
specialist doctors, external testing and vaccination facilities, hos-
pitals for detoxification).  The term referral is defined as directing 
clients to a source for help or information at another agency (this 
can also be another branch of the own parent organisation).
13Referral to social services
14 Referral to medical services
15 Opioid overdose interven-
tions
Number of emergency interventions carried out by agency staff  
in drug users who show severely impaired consciousness as a 
consequence of opioid (drug) consumption, and where oxygen 
mask or cardio-pulmonary resuscitation (CPR) or naloxone (a 
potent opioid antagonist to counteract respiratory depression) 
had to be used. Any overdose emergency intervention carried out 
by agency staff is counted, including when it took place outside 
of the premises of the agency. 
16 Stimulant overdose inter-
ventions
Number of emergency interventions carried out by agency staff  in 
drug users who show signs of cocaine overdose or other stimu-
lant overdose. The signs of stimulant overdose are not as clear-
cut as in opioid OD, but may include: acute agitation, excitement 
up to confusion; cardiac arrhythmias; and seizures. Any stimulant 
overdose emergency intervention carried out by agency staff is 
counted, including when it took place outside of the premises of 
the agency.
Table . Additional core-services for agencies with supervised consumption facility
17 Supervised injecting drug 
consumptions
Recorded should be the number of times drug users have stayed 
in the supervised consumption area of the agency for the purpose 
of drug injecting.  Consumptions are counted as one incident or 
‘episode’ even when repeated injections take place at the same oc-
casion. When the same client uses the facility several times on the 
same day, each time is recorded separately.
18 Supervised non-injecting 
drug consumptions
Recorded should be the number of times drug users have stayed in 
the supervised consumption area of the agency for the purpose of 
non-injection drug use. Consumptions are counted as one incident 
or ‘episode’ even when repeated consumptions take place at the 
same occasion. When the same client uses the facility several times 
on the same day, each time is recorded separately.
‘Services-based’ monitoring
The easiest and probably most common approach to monitor the utilization of the core-services is to 
record the number of items given out, of medical, psychological or referral services performed during 
the reporting period and to report the total number according to reporting period (usually one year). 
The reporting table is simple, as shown in the example of a completed reporting table (Table 3) shown 
below.
Table 3. Example of a completed reporting table for ‘services-based’ monitoring
Core-services (indicators) Number of times the service was provided during 
the reporting period
1 Syringes out 103.406
 Syringes in 96.588
3 Male condoms 6.788
4 HepB vaccination 58
… etc. …
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15 Opioid overdose interventions 35
16 Stimulant overdose interventions 66
17 Supervised injecting drug consumption 3.689
18 Supervised non-injecting drug consumption 4.760
This system of documentation allows to obtain very basic information on the volume of service delivery 
but does not link any information to clients.
‘Client-based’ monitoring 
To collect information about which individual clients’ service use patterns, a client information system 
should be in place. In these cases, clients are provided with an individual code, or specific ID card, and 
have to identify themselves with this code in order to receive the services. Identification of the individual 
client is normally required for medical interventions like vaccinations. Specific identification systems can 
be established at the level of the agency, at regional service level, or nationally; records can be kept 
fully confidential when information is compiled in specific reporting tables. Where such identification 
is in place socio-demographic and drug use data according to TDI protocol or at least the ‘reduced’ 
set of client characteristics should be registered in a database. The protocol can be downloaded at 
http://www.emcdda.europa.eu/?nnodeid=140. 
The reduced dataset proposed as minimum dataset in client-based monitoring consists of the seven 
variables listed below. Clients are registered upon the first contact with the agency, their records are 
kept in a database. Service delivery is documented through the use of a client-ID. 
(1) year of birth
() gender
(3) primary drug 
(4) usual route of administration primary drug
(5) already receiving substitution treatment (7)
(6) Ever/currently (last 30 days) injected (any drug). 
Definitions and details are provided in the TDI protocol.
Variables (3) to (6) should be updated in the client database at least every 1 months. Rules for regular 
updating should be defined at the agency.
Clients datasets are centrally registered at the agency and  updated in regular predefined intervals. De-
pending on the system, double-counting of clients can be prevented at national and inter-institutional 
level, or at least inside the agency different service provision areas. Such systems have to be designed 
within the local conditions and national data protection laws. They are easier to implement when elec-
tronic means (ID cards) are used and when the agency has a computer-network that links all service 
areas to a central database. They provide excellent possibilities for obtaining detailed statistical records 
of service demand which are needed to analyse patterns of service use. While this model delivers the 
most relevant data, it is rarely implemented for reasons of data protection and problems related to lack 
of feasibility in typical harm reduction settings like ‘drop-in’ centers or street work. 
7  Variable included in the original TDI dataset but moved to voluntary collection in 003.
 54
‘Contact-based’ monitoring
An alternative method to obtain core information about the characteristics of service users while not 
requiring identification, is based on staff observations during the contact with the client. Each time a 
core-service is utilized, during a contact with the client, staff classifies the client according to specific 
variables. In the example in Table 4 below, the chosen variables are: gender, injecting status and age 
group.  
Table 4. Example of a completed reporting table for ‘contact-based’ monitoring
Core-service 4: Number of doses of Hep B vaccine provided during last calendar year to 
specified client groups:
Gender male female unknown
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Total
Younger 
than 15
3 7 6 5 6  0 0 1 30
15-4 36 10 1 6 6 0 0 0  61
5-39 5 3 0 44 8 4 0 0 0 14
40 and 
older
7 9 0 10 6 0 0 0 0 3
unknown 7 0 0 3 1 0 0 0 0 11
Total 78 49 7 68 47 6 0 0 3 58
This approach is often chosen by agencies that don’t require client identification but would still like 
to analyse their service provision in some detail, as the results give some insight into the service user 
populations. It is challenging for staff, who are required to assess the client variables each time they 
deliver a service and to note the frequencies of service delivery in a table prepared for the respective 
subgroups. Few variables result already in a complex reporting table; the example above gender x 
injecting x four age groups results already in a  table with (3x3x5) 45 fields. 
The limitations of the method are that certain variables can not always be properly assessed (e.g. drug 
injecting status or age group) which results in missing data. The short duration of contacts between 
staff and clients (e.g. syringe exchange at a large agency) and the conditions of service delivery in 
outreach/street settings can make it difficult to assess client data.
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